{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:25:23Z","timestamp":1790259923597,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010954","name":"Qingdao National Laboratory for Marine Science and Technology","doi-asserted-by":"publisher","award":["2018SDKJ0403"],"award-info":[{"award-number":["2018SDKJ0403"]}],"id":[{"id":"10.13039\/501100010954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003584"],"award-info":[{"award-number":["82003584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH343"],"award-info":[{"award-number":["ZR2020QH343"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bioorg.2021.105343","type":"journal-article","created":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T19:17:22Z","timestamp":1631387842000},"page":"105343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapy"],"prefix":"10.1016","volume":"116","author":[{"given":"Kairui","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leqiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105343_b0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/med.20044","article-title":"Aminopeptidase-n\/cd13 (ec 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects","volume":"26","author":"Bauvois","year":"2006","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2021.105343_b0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","article-title":"The moonlighting enzyme cd13: Old and new functions to target","volume":"14","author":"Mina-Osorio","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"579","key":"10.1016\/j.bioorg.2021.105343_b0015","doi-asserted-by":"crossref","first-page":"eaav5938","DOI":"10.1126\/scisignal.aav5938","article-title":"Cd13 tethers the iqgap1-arf6-efa6 complex to the plasma membrane to promote arf6 activation, \u03b21 integrin recycling, and cell migration","volume":"12","author":"Ghosh","year":"2019","journal-title":"Sci. Signal."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105343_b0020","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1073\/pnas.1120790109","article-title":"Cooperative effects of aminopeptidase n (cd13) expressed by nonmalignant and cancer cells within the tumor microenvironment","volume":"109","author":"Guzman-Rojas","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2021.105343_b0025","doi-asserted-by":"crossref","unstructured":"E. Dondossola, R. Rangel, L. Guzman-Rojas, E. M. Barbu, H. Hosoya, L. S. St John, J. J. Molldrem, A. Corti, R. L. Sidman, W. Arap, R. Pasqualini,Cd13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis, Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 20717-20722.","DOI":"10.1073\/pnas.1321139110"},{"key":"10.1016\/j.bioorg.2021.105343_b0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3727\/096504020X15919605976853","article-title":"Cd13: A key player in multidrug resistance in cancer chemotherapy","volume":"28","author":"Guo","year":"2020","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bioorg.2021.105343_b0035","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1002\/ctm2.233","article-title":"Cd13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating hdac5-lsd1-nf-\u03bab oncogenic signaling","volume":"10","author":"Hu","year":"2020","journal-title":"Clin. Transl. Med."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105343_b0040","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1172\/JCI42550","article-title":"Cd13 is a therapeutic target in human liver cancer stem cells","volume":"120","author":"Haraguchi","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2021.105343_b0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/ijo.2016.3496","article-title":"A cd13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma","volume":"49","author":"Yamashita","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2021.105343_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.660377","article-title":"Suppression of cd13 enhances the cytotoxic effect of chemotherapeutic drugs in hepatocellular carcinoma cells","volume":"12","author":"Ji","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105343_b0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/ped.12597","article-title":"Prognostic significance of aminopeptidase-n (cd13) in hepatoblastoma","volume":"57","author":"Saida","year":"2015","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.bioorg.2021.105343_b0060","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/893243","article-title":"Expression of myeloid antigen in neoplastic plasma cells is related to adverse prognosis in patients with multiple myeloma","volume":"2014","author":"Shim","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bioorg.2021.105343_b0065","first-page":"1503","article-title":"Clinical significance of aminopeptidase n\/cd13 expression in human pancreatic carcinoma","volume":"9","author":"Ikeda","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2021.105343_b0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/gast.2002.31095","article-title":"Aminopeptidase n is involved in cell motility and angiogenesis: Its clinical significance in human colon cancer","volume":"122","author":"Hashida","year":"2002","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105343_b0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/0973-1482.138007","article-title":"Expression and clinical significance of aminopeptidase n\/cd13 in non-small cell lung cancer","volume":"11","author":"Zhang","year":"2015","journal-title":"J. Cancer Res. Ther."},{"issue":"15","key":"10.1016\/j.bioorg.2021.105343_b0080","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1021\/acs.jmedchem.7b00782","article-title":"Design of aminopeptidase n inhibitors as anti-cancer agents","volume":"61","author":"Amin","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105343_b0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-020-00865-7","article-title":"Cd13 as a new tumor target for antibody-drug conjugates: Validation with the conjugate mi130110","volume":"13","author":"Dom\u00ednguez","year":"2020","journal-title":"J. Hematol Oncol."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105343_b0090","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/med.20238","article-title":"Targeted drug delivery and penetration into solid tumors","volume":"32","author":"Corti","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2021.105343_b0095","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/cancers12061488","article-title":"First-in-class cd13-targeted tissue factor ttf-ngr in patients with recurrent or refractory malignant tumors: Results of a phase i dose-escalation study","volume":"12","author":"Schliemann","year":"2020","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bioorg.2021.105343_b0100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejmech.2016.05.068","article-title":"Discovery of bc-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent","volume":"121","author":"Jiang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105343_b0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2017.11.074","article-title":"Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy","volume":"143","author":"Jiang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105343_b0110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3389\/fphar.2018.01042","article-title":"Cd13 inhibition enhances cytotoxic effect of chemotherapy agents","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105343_b0115","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3892\/ijo.2017.4159","article-title":"Bc-02 eradicates liver cancer stem cells by upregulating the ros-dependent DNA damage","volume":"51","author":"Dou","year":"2017","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.bioorg.2021.105343_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103158","article-title":"Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer","volume":"91","author":"Skarbek","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105343_b0125","doi-asserted-by":"crossref","first-page":"104200","DOI":"10.1016\/j.bioorg.2020.104200","article-title":"Nqo1-selective activated prodrugs of combretastatin a-4: Synthesis and biological evaluation","volume":"103","author":"Zhang","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105343_b0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2017.11.021","article-title":"Circadian variations in the pharmacokinetics of capecitabine and its metabolites in rats","volume":"112","author":"Kobuchi","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105343_b0135","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1021\/ml3000758","article-title":"Development of synthetic aminopeptidase n\/cd13 inhibitors to overcome cancer metastasis and angiogenesis","volume":"3","author":"Su","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105343_b0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejmech.2013.03.043","article-title":"Synthesis and biological evaluation of n-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth","volume":"64","author":"Xu","year":"2013","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821007203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821007203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:30:03Z","timestamp":1758616203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821007203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"alternative-id":["S0045206821007203"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105343","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105343"}}